Ads
related to: abbvie's nyse- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- Investor Resources
schwab.com has been visited by 100K+ users in the past month
Search results
AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.48
Simply Wall St. via Yahoo Finance· 1 year agoThe board of AbbVie Inc. (NYSE:ABBV) has announced that it will be paying its dividend of $1.48 on...
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
Simply Wall St. via Yahoo Finance· 5 months agoAbbVie Inc.'s (NYSE:ABBV) dividend will be increasing from last year's payment of the same period to...
AbbVie's (NYSE:ABBV) Upcoming Dividend Will Be Larger Than Last Year's
Simply Wall St. via Yahoo Finance· 2 years agoAbbVie Inc. (NYSE:ABBV) will increase its dividend from last year's comparable payment on the 15th...
Do Humira Biosimilars Threaten AbbVie's Dividend?
Motley Fool· 1 year agoPharmaceutical giant AbbVie (NYSE: ABBV) is known for its top-selling drug Humira and its lucrative dividend that yields more than 4% at the current...
AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three...
Simply Wall St. via Yahoo Finance· 10 months agoOne simple way to benefit from the stock market is to buy an index fund. But if you choose...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 month agoAbbVie's acquisition of ImmunoGen strengthens its oncology pipeline and solid tumor capabilities. Robust financial performance with $12.3 billion in net...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 2 weeks agoWall Street is feeling pretty good about AbbVie's (NYSE: ABBV) performance in 2024 so far. Louise...
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
Motley Fool via Yahoo Finance· 4 months agoThere are thousands of drugs on the market, and there are thousands more that are no longer in use....
Is This the Start of a Nightmare for AbbVie Stock?
Motley Fool· 1 year agoWith a small army of Wall Street analysts predicting on average that AbbVie's (NYSE: ABBV) revenue will shrink in 2023 as well as in 2024, investors are...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 4 days agoSometimes, misperceptions can work in investors' favor. When others think the outlook for a stock isn't so great, you can win big if that view is overly...
Ad
related to: abbvie's nyse
